Axogen, Inc.

AXGN ·Healthcare, Medical Devices, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Assets
Cash & Equivalents $35.5M $27.6M $31.0M $15.3M $32.8M $48.8M $35.7M $24.3M
Accounts Receivable $26.2M $24.1M $25.1M $22.2M $18.2M $17.6M $16.9M $15.3M
Inventory $42.4M $33.2M $23.0M $18.9M $16.7M $12.5M $13.9M $12.0M
Total Current Assets $120.4M $99.2M $88.0M $98.1M $127.0M $145.3M $135.0M $151.0M
Property, Plant & Equipment — — — — $62.9M $38.4M $14.9M $8.0M
Goodwill — — — — — — — —
Intangible Assets (Excl. Goodwill) $6.8M $5.6M $4.5M $3.6M $2.9M $2.1M $1.5M $1.2M
Total Assets $221.7M $203.7M $196.8M $195.4M $208.0M $201.4M $154.6M $160.2M
Liabilities
Accounts Payable $2.9M $8.0M $11.8M $9.0M $5.9M $4.6M $8.3M $4.5M
Total Current Liabilities $23.6M $30.6M $30.4M $23.8M $24.3M $22.8M $20.9M $13.0M
Long-Term Debt $48.4M $47.5M $46.6M $45.7M $44.8M $32.0M $0 $35.0K
Total Liabilities $92.8M $99.8M $101.2M $94.4M $95.5M $78.2M $22.5M $13.2M
Stockholders' Equity
Retained Earnings $-307.0M $-291.3M $-281.3M $-259.6M $-230.6M $-203.6M $-179.9M $-150.7M
Total Stockholders' Equity $128.8M $103.9M $95.7M $101.0M $112.6M $123.1M $132.2M $147.0M
← Newer Page 1 of 2 Older →